KBC Group’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,581
Closed -$39K 1901
2024
Q1
$39K Buy
1,581
+651
+70% +$19.4K ﹤0.01% 1680
2023
Q4
$34K Hold
930
﹤0.01% 1754
2023
Q3
$45K Buy
+930
New +$55.3K ﹤0.01% 1537
2014
Q1
Sell
-1,763
Closed -$47K 1335
2013
Q4
$47K Sell
1,763
-2,114
-55% -$53K ﹤0.01% 1230
2013
Q3
$78K Sell
3,877
-92
-2% -$1.63K ﹤0.01% 1111
2013
Q2
$51K Buy
+3,969
New +$36.9K ﹤0.01% 1168

Other funds holding PRTA

KBC Group's PRTA Position: Q2 2024 in Review

KBC Group sold out of Prothena Corp (PRTA) in Q2 2024, closing a stake of 1,581 shares — an estimated $39K sold.

KBC Group first reported a position in PRTA in Q2 2013 and held it in 6 quarters. The position peaked at $78K in Q3 2013. 160 funds tracked by Wall St. Rank hold PRTA as of Q2 2024.

  • KBC Group reported no remaining Prothena Corp position as of Q2 2024 after selling out during the quarter.
  • KBC Group sold 1,581 Prothena Corp shares in Q2 2024, an estimated $39K.
  • KBC Group first reported a position in Prothena Corp in Q2 2013 and held it in 6 quarters.
  • KBC Group's Prothena Corp position peaked at $78K in Q3 2013.
  • 160 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2024.

Based on KBC Group's 13F filing for Q2 2024, filed 17 Jul 2024.